Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BioStock Investor Meeting: Interview with Arcede Pharma

Arcede Pharma, which just released its first quarterly report as a separately listed company, presented at the BioStock Investor Meeting in September. In connection with the event, BioStock took the opportunity to interview the company's CEO Mia Lundblad regarding drug candidate RCD405. The candidate, which is developed to treat of COPD and severe asthma, is currently being prepared for clinical phase I.See the full interview at biostock.se:https://www.biostock.se/en/2022/09/biostock-investor-meeting-interview-with-arcede-pharma/This is a press release from BioStock - Connecting

Peab builds substation in Nordreisa

Peab has been commissioned to take responsibility for construction and concrete work at Vinnelys substation in Nordreisa Municipality. The customer is Statnett SF and the contract is worth NOK 169 million.Nordreisa substation began operating in 1971 and is a hub in the Northern Network in Norway that comprises most of the 132 kV network in Troms County and Finnmark County. Now capacity needs to be upgraded, primarily due to developments in the fishing industry and a higher degree of electrification. In connection with the new 420 kV Balsfjord-Skaidi power line a permit has been granted

Brain+ partners with German medical distributor – and advances launch of its first CST dementia product in Germany to Q2 2023

Copenhagen, Denmark, September 28, 2022 – Brain+ A/S (Nasdaq First North: BRAINP) · Through Coopmed, Brain+ will be represented by experienced and local medical sales managers in Germany and begin to build the customer pipeline in preparation for the commercial launch of its first CST dementia product, CST-Therapist Companion · In partnership with Rox Health (part of Roche Germany), Brain+ has successfully completed the regulatory and commercial preparation of CST-Therapist Companion for the German market and now advances its launch plan with six months to Q2 2023 · The German

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 195 - 28 SEPTEMBER 2022  In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcement no. 158/22. A/S Motortramp participates in NORDEN’s share buy-back program by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in NORDEN.     Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Thomas France, Investor

New partnership to solve commuting challenges and congestion on the roads

Donkey Republic is happy to announce that they will be partnering with DSB to improve the daily lives of commuters with Kørmit. Company Announcement No. 14 2022The partnership will be launched on October 3rd in Malmparken St. with GEN2 pedal bikes, and ongoing nationwide scale up is expected until the end of July next year.  DSB offers Kørmit as a last-mile mobility solution that puts DSB in the center of sustainable travels by making it easier to get from station to work. Kørmit's bigger ambition is in alignment with Donkey Republic's mission to make bike sharing service as part of

BioStock Investor Meeting: Interview with Lipum

Biopharmaceutical company Lipum is approaching clinical studies with the candidate SOL-116, which targets chronic inflammatory diseases such as rheumatoid arthritis. CEO Einar Pontén presented the company at the BioStock Investor Meeting in Stockholm and BioStock had the opportunity to interview Pontén about the upcoming clinical study and what distinguishes SOL-116 from today’s treatments.See the full interview at biostock.se:https://www.biostock.se/en/2022/09/biostock-investor-meeting-interview-with-lipum/This is a press release from BioStock - Connecting Innovation & Capital. https://

Fazer brings delicious novelties to TFWA in Cannes

As passenger traffic rebounds all over the world, also the global Travel Retail and Duty-Free market has slowly started recovering from the lowlands caused by the Covid-19 pandemic. Traditionally strong in travel retail, Fazer is back at the TFWA World Exhibition and Conference in Cannes with an offering celebrating its most popular products complemented by some delicious novelties.Fazer is Finland’s leading producer of chocolate, sweets and biscuits. The confectionery production is located in Finland and products are exported to some 40 countries globally.   Fazer has a long

AcuCort reports positive results from the company’s questionnaire study about allergy treatments

AcuCort AB (publ) (Spotlight Stock Market: ACUC) reports today positive results from the company's questionnaire study on how allergy patients value their treatment. The results from the study will be included in the documentation in AcuCort's upcoming pricing and reimbursement application to the Swedish Dental and Pharmaceutical Benefits Agency, TLV.The questionnaire study includes a total of 426 patients who have answered questions about their allergy and how they value the available treatment options. From the beginning, just over 100 patients would have been included in the study, but

KONE to equip phase one of Metro Line 16 in Xian, China

KONE Corporation, press release, September 28, 2022   KONE Corporation, a global leader in the elevator and escalator industry, has won an order to supply a suite of People Flow® solutions, including 40 elevators and 104 escalators, for a new metro line in Xian, China  The first phase of Xian Metro Line 16, located in Fengdong New Town in Xixian New District, is 15 km long, with nine underground stations. There are various popular destinations along the metro line, such as historical sites and parks, making it a crucial development for the city’s transportation network.

NATO Air Base Geilenkirchen goes live with Digital Tower from Saab

The first digital air traffic control tower is now live and in operation at NATO Air Base Geilenkirchen in Germany. The base is equipped with a state-of-the-art Saab r-TWR system.Saab’s r-TWR is the first military digital tower solution fully operational in NATO and is certified by the the German Military Aviation Authority (LufABw). NATO’s main operation base for its Boeing E-3A airborne early warning and control system fleet in Geilenkirchen, Germany will be using the Saab r-TWR in all weather conditions. The solution will service a complex military airbase with aircraft types ranging

From shopping boats to floating bridges - Stena Line celebrates its 60[th] anniversary

Six decades of ambition, flexibility and curiosity has made Stena Line a global leader in ferry shippingToday we celebrate Stena Line’s 60[th] anniversary as a ferry company, having established itself as a trusted link between people, places and societies. When Sten A. Olsson, the founder of Stena Line, opened a shipping service from his hometown Göteborg to Skagen in Denmark in 1962, he did so with 20 years of entrepreneurial experience – as a scrap merchant. Where others saw waste, he saw business opportunities, laying the foundations for what should become one of the most iconic brands

Detection Technology’s financial calendar for 2023

Detection Technology Plc company announcement 28 September 2022 at 10:00 (EEST) Detection Technology’s financial calendar for 2023 Detection Technology Plc will disclose the following financial releases in 2023: · Financial statements review 2022: 2 February 2023 · Business review January–March 2023: 27 April 2023 · Half-yearly report January–June 2023: 3 August 2023 · Business review January–September 2023: 27 October 2023 The financial statements and annual review for 2022 will be published latest on 9 March 2023 on the company’s website. The Annual General Meeting

Invitation to SCA’s Q3 2022 press conference

The press conference, held in connection with the publication of SCA’s interim report for the third quarter of 2022, will be available via webcast or by phone.The interim report will be published on October 28, 2022, at approximately 08:00 CET. The subsequent webcast press conference will be held at 10:00 at Tändstickspalatset, Västra Trädgårdsgatan 15 in Stockholm.   At the press conference, President and CEO Ulf Larsson and CFO Andreas Ewertz will present and answer questions regarding the report.   The press conference will be webcast live at www.sca.com. It is possible to

The Future of Energy: Transition & Security Program

September 27- 29, 2022 Wednesday, September 28 7:30 AM – 8:30 AM     Registration & Continental Breakfast 8:30 AM – 8:40 AM     Opening Remarks Jennifer Josefson, 2021-2022 AIEN President; Partner, Morgan Lewis 8:45 AM – 9:40 AM     Keynote Address: Energy Security: The New Global Imperative The Rt. Hon. Lord Robertson of Port Ellen KT, GCMG, honFRSE, PC, Former NATO Secretary General and UK Defense Secretary The war in Ukraine has demonstrated to the world once again how dependent many countries are on energy supplies from fragile nations and regions. How

Neogap strengthens its board with two new members

Neogap Therapeutics AB, developing individualised immunotherapy for cancer treatment, strengthens the board with two new members. Anna Kälvemark and Steve Glavas both have experience in transforming start-ups into successful companies and contribute with cutting-edge expertise in regulatory activities and commercialisation of life science companies.At Neogap Therapeutics' annual general meeting on May 20, Anna Kälvemark and Steve Glavas were elected new board members. "We would like to extend a warm welcome to Anna Kälvemark and Steve Glavas to Neogap's board. They are an ideal

Handheld releases new Nautiz X81: An ultra-rugged 5G Android 12 handheld with a familiar feel

Handheld Group , a leading manufacturer of rugged mobile computers, today announced the release of the all-new Nautiz X81, an ultra-rugged Android handheld joining the popular Nautiz line with expanded outdoor-rugged reliability, 5G connectivity, as well as nearly limitless customization capability.The innovative 4.8-inch screen uses unique display technology to deliver a truly sunlight-readable screen for outdoor work – without draining the battery life. The new Nautiz X81 

Sweden, the land of IKEA, ABBA, Meatballs and…Mythology?

Over a half (59%) of Brits connect Sweden with Eurovision legends ABBA. · Brits are missing out on Sweden’s rich culture, with only a fifth (21%) aware of Swedish folklore and less than a sixth (14%) of the nation’s mythological heritage. · Over half (57%) take walks in nature to escape everyday life. · Visit Sweden invites travellers to the forests of Sweden to discover the home of the nation’s folklore with chilling new audio story by international bestselling author John Ajvide Lindqvist. 28th September 2022: New research from Visit Sweden reveals that IKEA, pop group ABBA

VagiVital® AL for amniotic leakage detection now commercially available

Peptonic Medical today announced that VagiVital® AL Self-Test for amniotic fluid leakage detection is now commercially available for sale in its own online store. Distribution will be continuously broadened to pharmacies and international partners in the coming year.VagiVital® AL is a patented self-test to detect amniotic fluid leakage. VagiVital® AL in short; · A unique patented technology designed to detect amniotic leakage · Comes in the form of a panty liner where the patented technology is embedded · Can distinguish between amniotic fluid and urine with 97% accuracy

BioStock Investor Meeting: Interview with WntResearch

The last few months have been eventful for cancer therapy company WntResearch. In August, the company announced unexpected and promising findings with the candidate Foxy-5 in the phase II study Neofox, which prompted the company to change its plans for the study. CEO Pernilla Sandwall told us more about the updated study strategy in connection with the BioStock Investor Meeting.See the full interview at biostock.se:https://www.biostock.se/en/2022/09/biostock-investor-meeting-interview-with-wntresearch/This is a press release from BioStock - Connecting Innovation & Capital. https://www.

TePe supports the Pink Ribbon initiative in favour of cancer awareness and research

This October, oral health company TePe will once again support the Pink Ribbon by offering health-promoting products in favour of cancer research.October is the breast cancer awareness month when organisations and individuals join forces to support cancer research. As an international company committed to sustainability and health awareness, TePe engages in Pink Ribbon initiatives all over the world. Last year, TePe’s global initiatives contributed over €100,000 to the cause. Katia Saltidou, Marketing Director at TePe, said, “We constantly work to promote long-term health and encourage

Atea receives BBB+ credit rating from Nordic Credit Rating

Nordic Credit Rating (NCR) has today assigned a first-time long-term issuer rating of ‘BBB+’ with a ‘Stable’ outlook to Atea ASA. NCR comments in its report, “Our ‘BBB+’ long-term issuer credit rating of Norway-based IT infrastructure provider Atea reflects the company’s low financial leverage as a result of strong operating cash flow and low investment requirements. It also reflects Atea’s strong position as the largest provider of IT infrastructure in each of its markets in the Nordic and Baltic regions and the third largest provider in Europe. We see the company’s focus on the public

Risk Intelligence A/S signs 5-year contract for the Risk Intelligence System with the U.S. Navy Naval Information Warfare Center

Risk Intelligence A/S (“Risk Intelligence”) announces today that the company has signed a 5-year API license agreement for the Risk Intelligence System (MaRisk+PortRisk) with the U.S. Navy Naval Information Warfare Center (NIWC) with a total contract value for the 5-year period of 1,701,716 USD.The Risk Intelligence maritime security data is integrated through an API into a U.S. Navy Maritime Domain Awareness (MDA) software suite used by the U.S. Navy and other parts of the U.S. defence.  The 5-year contract follows annual contracts for the license periods 2018/2019 to 2021/2022 and will

BioStock Investor Meeting: Interview with Cyxone

Cyxone’s interim CEO Carl-Magnus Högerkorp was interviewed by BioStock after his presentation at the BioStock Investor Meeting. In the interview, Högerkorp tells us more about the upcoming phase II study with the company’s leading candidate Rabeximod, and answers the question of where the company expects to be in a year.See the full interview at biostock.se:https://www.biostock.se/en/2022/09/biostock-investor-meeting-interview-with-cyxone/This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

There are no items matching the current filter
There are no more items matching the current filter
Back to top